Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Eisai cancer, neurology, endocrine/metabolic news

    Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Cancer, Neurology, Endocrine/Metabolic Eisais Eisai Inc. U.S. subsidiary plans to cut about 25% of its 1,700-person workforce and will focus on the development of …

    Published on 4/13/2015
  • GeneOne, Inovio, AstraZeneca, Emory University, U.S. Department of Defense, University of Pennsylvania, Vanderbilt University infectious news

    GeneOne Life Science Inc. (KSE:01100), Seoul, South Korea Inovio Pharmaceuticals Inc. (NASDAQ:INO), Blue Bell, Pa. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Emory University, Atlanta, Ga. U.S. Department of …

    Published on 4/13/2015
  • Otsuka Pharmaceutical neurology news

    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Business: Neurology Otsuka filed a suit in the U.S. District Court for the District of Maryland alleging that FDA unlawfully broadened the approved indication for Otsukas …

    Published on 4/13/2015
  • Shire, Hayman Capital Management gastrointestinal news

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Hayman Capital Management, Dallas, Texas Business: Gastrointestinal A hedge fund filed two inter partes reviews (IPRs) in the Patent Trial and Appeals Board of the U.S. …

    Published on 4/13/2015
  • TransCelerate pharmaceuticals news

    TransCelerate BioPharma Inc., Philadelphia, Pa. Business: Pharmaceuticals Not-for-profit biopharma consortium TransCelerate launched the Placebo/Standard of Care Data Sharing and the e-Labels initiatives. The Placebo/…

    Published on 4/13/2015
  • Veeva Systems, Zephyr Health bioinformatics news

    Veeva Systems, Pleasanton, Calif. Zephyr Health Inc., San Francisco, Calif. Business: Bioinformatics Zephyr joined Veevas OpenKey partner program under a data access agreement to provide life sciences companies with …

    Published on 4/13/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Novartis Sandoz Inc. generics unit filed an opposition brief to Amgens motion seeking a …

    Published on 4/6/2015
  • BioCryst, U.S. Department of Health and Human Services infectious news

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 4/6/2015
  • Catamaran, UnitedHealth Group other news

    Catamaran Corp. (NASDAQ:CTRX; TSX:CCT), Schaumburg, Ill. UnitedHealth Group Inc. (NYSE:UNH), Minneapolis, Minn. Business: Other The OptumRx Inc. pharmacy benefit manager unit of UnitedHealth will acquire fellow PBM …

    Published on 4/6/2015
  • Vivus endocrine/metabolic news

    Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Business: Endocrine/Metabolic Vivus plans to reduce contractual sales representatives for obesity drug Qsymia phentermine/topiramate to about 100 from about 150. The …

    Published on 4/6/2015
  • AcelRx Pharmaceuticals Inc neurology news

    AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX), Redwood City, Calif. Business: Neurology AcelRx will reduce headcount by 19 (36%) to focus resources on seeking FDA approval of Zalviso sufentanil sublingual tablet system and …

    Published on 3/30/2015
  • Amgen Inc, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Amgen filed an appeal in the U.S. Court of Appeals for the Federal Circuit (CAFC) of a …

    Published on 3/30/2015
  • Emergent BioSolutions Inc, U.S. Department of Health and Human Services infectious news

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 3/30/2015
  • Forma Therapeutics, Cancer Research UK cancer news

    Forma Therapeutics Inc., Watertown, Mass. Cancer Research UK, London, U.K. Business: Cancer Forma and the not-for-profits commercial arm, Cancer Research Technology Ltd., launched two virtual companies to develop …

    Published on 3/30/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. District Court for the Northern District of California denied Amgens motions seeking …

    Published on 3/23/2015
  • Biogen Idec, Eli Lilly, GlaxoSmithKline, J&J, Pfizer, Alzheimers Research UK, U.K. Department of Health neurology news

    Biogen Idec Inc.(NASDAQ:BIIB), Cambridge, Mass. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Pfizer Inc. (NYSE:…

    Published on 3/23/2015
  • Discovery Laboratories pulmonary news

    Discovery Laboratories Inc. (NASDAQ:DSCO), Warrington, Pa. Business: Pulmonary Discovery Laboratories disclosed in its 2014 financial results that it will restructure to focus on development of Aerosurf aerosolized KL4…

    Published on 3/23/2015
  • Enzo, Thermo Fisher genomics news

    Enzo Biochem Inc. (NYSE:ENZ), Farmingdale, N.Y. Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. Business: Genomics The U.S. Court of Appeals for the Federal Circuit (CAFC) vacated a lower court judgment that …

    Published on 3/23/2015
  • Amgen cancer news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Cancer Amgen will close the headquarters of its cancer-focused Onyx Pharmaceuticals Inc. subsidiary in South San Francisco, California, and lay off about 300 of …

    Published on 3/16/2015
  • BioMarin, Sanofi, Duke University endocrine/metabolic news

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Duke University, Durham, N.C. Business: Endocrine/Metabolic The U.S. Patent and Trademark Offices Patent Trial …

    Published on 3/16/2015
  • Canon other news

    Canon Inc. (Tokyo:7751; NYSE:CAJ), Tokyo, Japan Business: Other Canon established Canon BioMedical Inc., a wholly owned subsidiary to serve as a headquarters for its biomedical business. The subsidiary will develop and …

    Published on 3/16/2015
  • Celltrion, Hospira, J&J, New York University autoimmune, biosimilars news

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. New York University, New York, N.Y. Business: Autoimmune, Biosimilars …

    Published on 3/16/2015
  • Merck pharmaceuticals news

    Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Pharmaceuticals Merck discontinued discovery and non-clinical operations at its Cubist Pharmaceuticals Inc. subsidiary in Lexington, Massachusetts. The …

    Published on 3/16/2015
  • Mitsubishi Tanabe Pharma, U.S. Department of Health and Human Services infectious news

    Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded…

    Published on 3/16/2015
  • IDRI, U.S. Department of Health and Human Services infectious news

    Infectious Disease Research Institute (IDRI), Seattle, Wash. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious IDRI said HHSs Biomedical Advanced Research and Development Authority (…

    Published on 3/9/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993